KOSDAQElectronic Components091120

EM-Tech

₩5,810▲ 5.44%2026-10-02 close
Market Cap
₩98.5B
Turnover
₩300M
Volume
60,000 shares
Shares out.
17.1M
PER
—
PBR
0.5×
EPS
-₩968
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close

01

Report overview

EM-Tech at an Inflection Point Amid Ongoing Losses

EM-Tech's core mobile acoustic component business is under pressure from a slowing handset cycle, leaving the commercialization of new ventures such as e-cigarette devices and auto-injectors as the key swing factor for its future results.

  1. 1

    2025 consolidated revenue rebounded to KRW 205.1 billion year on year, but the company posted an operating loss of KRW 19.9 billion and an owners' net loss of KRW 11.5 billion, marking a fourth consecutive year of losses.

  2. 2

    Quarterly revenue trended lower across 2025Q3 through 2026Q2, while the operating loss widened to KRW 10.1 billion in 2025Q4 before remaining volatile.

  3. 3

    The component business (micro speakers, dynamic receivers, etc.) accounts for roughly 92% of revenue, with the product business, including e-cigarette devices and auto-injectors, making up about 8% as of 2026Q2.

  4. 4

    A new e-cigarette product has completed development and mass-production preparation and awaits the customer's launch decision, while the auto-injector completed FDA DMF registration in July 2025 and is undergoing further certification steps.

  5. 5

    Financial strain has increased, with 2025 operating cash flow turning negative at KRW -15.8 billion and the debt ratio rising to 73.1%.

02

Business structure

Founded in 2001 and listed on KOSDAQ in 2007, EM-Tech is a specialist electronic component and device maker organized into a component business division and a product business division.

The component division centers on micro speakers, dynamic receivers, module assemblies, and vibration motors used in mobile handsets, smartwatches, and TWS earbuds, and is expanding into automotive electro-mechanical parts and haptic modules.

The product division is building e-cigarette devices and auto-injectors as its core growth businesses while also producing wireless earsets, smart hearing aids, and health and beauty care devices.

According to company-disclosed data, the component business generated roughly 92% of revenue and the product business about 8% as of 2026Q2. R&D and marketing are conducted domestically, while manufacturing runs on a dual structure across Korea and overseas plants in Vietnam and Indonesia.

The component business historically grew on the back of acoustic-parts supply to Samsung Electronics, and as the smartphone market matured, the company reinvested cash flow into new businesses such as e-cigarettes to diversify its structure.

In the e-cigarette segment, Sweden's Nolato has been cited as a global competitor, and EM-Tech continues co-development collaboration with major brands based on its proprietary intellectual property and product platform.

More recently, the company has expanded into automotive electronics, completing vendor registration with a global automaker and securing an order for a bendable display.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q2₩53.2B-₩1.5B−2.7%
2025Q3₩52.1B-₩4.4B−8.4%
2025Q4₩46.4B-₩10.1B−21.8%
2026Q1₩48.6B-₩4.8B−9.9%
2026Q2₩40.4B-₩7.3B−18.1%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩415.8B₩33.9B₩33.4B8.2%12.8%57.5%
2023₩263.5B-₩14.6B-₩11.8B−5.5%−4.8%65.4%
2024₩167.6B-₩30.5B-₩44.5B−18.2%−21.7%67.7%
2025₩205.1B-₩19.9B-₩11.5B−9.7%−5.9%73.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-23

04

Earnings analysis

Consolidated revenue rebounded to KRW 205.1 billion in 2025 from KRW 167.6 billion in 2024, yet the operating loss reached KRW 19.9 billion for a fourth straight year of losses, with an operating margin of -9.7%.

The owners' net loss narrowed to KRW 11.5 billion from KRW 44.5 billion in 2024, but the company still fell short of returning to profit.

Looking across the past four years, revenue of KRW 415.8 billion and operating profit of KRW 33.9 billion in 2022 sharply reversed into revenue of KRW 263.5 billion and an operating loss of KRW 14.6 billion in 2023, then revenue declined further with the operating loss widening to KRW 30.5 billion in 2024, before 2025 brought a revenue rebound alongside a somewhat narrower loss.

On a quarterly basis, revenue of KRW 53.2 billion with a KRW 1.5 billion operating loss in 2025Q2 gave way to KRW 52.1 billion and a KRW 4.4 billion loss in Q3, then KRW 46.4 billion and a KRW 10.1 billion loss in Q4 as losses widened sharply, before easing somewhat to KRW 48.6 billion revenue and a KRW 4.8 billion loss in 2026Q1, only to widen again to KRW 40.4 billion revenue and a KRW 7.3 billion loss in Q2.

The owners' net loss also grew from KRW 1.9 billion in 2025Q2 to KRW 3.9 billion in Q4 and KRW 5.5 billion in 2026Q2, the largest quarterly loss in the recent window.

Summed across the four quarters from 2025Q3 to 2026Q2, the owners' net loss totaled KRW 15.3 billion, indicating that the revenue rebound has not translated into a clear earnings improvement.

On the balance sheet, operating cash flow turned negative at KRW -15.8 billion in 2025 from a positive KRW 7.3 billion in 2024, and the debt ratio climbed steadily from 57.5% in 2022 to 73.1% in 2025, suggesting a gradually thinning capital cushion.

According to external media reports, the company has posted operating losses for 12 consecutive quarters amid weakness in the component business and rising new-business development costs.

05

Industry analysis

EM-Tech's core downstream market of smartphone and wearable components has matured, and demand volatility has increased.

In 2026Q1, revenue fell 9.1% year on year due to shifting demand in the smart device market, again confirming that the speaker component business is highly dependent on the handset market and reacts directly to trend changes there.

Conversely, on a cumulative basis through 2025Q3, revenue from mobile-handset parts such as micro speakers and dynamic receivers rose, driving revenue growth and a narrower loss during that period, underscoring that the component cycle swings significantly by quarter.

The e-cigarette market, which anchors the product business, is shaped by the new-product launch cycles of major global brands, and the company leverages manufacturing technology and automation capability accumulated in its component business to pursue co-development with major brands.

The digital healthcare and medical device market that houses the auto-injector business requires regulatory approvals such as FDA certification before commercialization, and several domestic players have already commercialized digital auto-injector products, forming a competitive landscape.

The automotive electronics segment is at an early entry stage via vendor registration and order wins with automakers, with related revenue yet to materialize meaningfully.

Competitors cited include Sweden's Nolato in e-cigarette devices and a range of small and mid-sized domestic component makers in acoustics and electronics. Overall, EM-Tech sits at a transition point where cyclicality in its core component business intersects with the commercialization timing of its new ventures.

06

Outlook

In its semiannual report, the company stated that it has designated e-cigarette devices and auto-injectors as the core growth businesses of its product division and is pursuing expansion through joint development and cooperation with major global customers.

The new e-cigarette product has completed development, with mass-production preparation nearly finished, and a company official indicated that development is complete and production readiness is nearly done, with the customer now in the process of deciding whether to launch.

Forecasts suggest that if the launch is confirmed, it could lead to full-scale production and expanded product-segment revenue. The auto-injector completed FDA DMF registration in July 2025 and is currently undergoing additional FDA certification procedures.

In the component business, the company is extending its application range beyond mobile-phone parts into smartwatches and wireless earbuds, while in automotive electronics it has completed vendor registration with a global automaker and secured an order related to a bendable display, targeting production start in the first quarter of 2028.

The next regular earnings report, for 2026Q3, is due to be filed by November 16, 2026.

Because commercialization timing for the new businesses still hinges on development-cost burdens and customer decisions, future earnings trends are likely to depend on both a seasonal recovery in the component business and the launch schedule of new products.

07

Valuation

PER
—
PBR
0.5×
ROE
-8.5%
EPS
-₩968
BPS
₩11,211
Dividend per share
₩0

With operating and net losses persisting over recent years, earnings-based valuation metrics are difficult to apply meaningfully to EM-Tech at this stage.

Relative to net asset value, the shares trade in a range below per-share book value, which can be interpreted as the market partially pricing in weak results and capital-erosion concerns.

In the past there were periods when earnings-based multiples ran higher on expectations tied to the e-cigarette and healthcare new businesses, but with losses continuing more recently such comparisons have become less meaningful. On dividends, the company has maintained a no-dividend policy amid continued net losses.

Ultimately, current valuation appears to reflect market expectations about the commercialization success of new businesses such as e-cigarettes, auto-injectors, and automotive electronics, along with the pace of recovery in the component business, more than it reflects past earnings.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-23

08

Bull factors

New Businesses Nearing Commercialization

The new e-cigarette product has finished development and production readiness, leaving only the customer's launch decision, while the auto-injector has completed FDA DMF registration and is undergoing additional certification.

If commercialized, both businesses have potential to diversify a revenue base currently concentrated in mobile-handset parts, and the company is also building a new growth axis in automotive electronics via vendor registration and an order win with a global automaker.

2025 Revenue Rebound and Narrower Losses

Consolidated revenue rebounded to KRW 205.1 billion in 2025, and the operating loss narrowed to KRW 19.9 billion from KRW 30.5 billion in 2024.

The owners' net loss also shrank sharply to KRW 11.5 billion from KRW 44.5 billion a year earlier, indicating that a partial recovery in the component business helped the earnings trajectory.

Expanding Component Portfolio

The component business is extending beyond mobile-handset parts into peripherals such as smartwatches and wireless earbuds, and on a cumulative basis through 2025Q3, growth in micro speaker and dynamic receiver sales drove an overall earnings improvement.

The company is also expanding into automotive electro-mechanical parts and haptic modules, broadening its customer base.

09

Bear factors

12 Consecutive Quarters of Operating Losses

According to media reports, EM-Tech has posted operating losses for 12 consecutive quarters amid weakness in the component business and rising new-business development costs.

The operating loss widened to KRW 10.1 billion in 2025Q4 and remained at KRW 7.3 billion in 2026Q2, showing that the loss-making trend has not been easily resolved and cost burdens may persist until the new businesses are commercialized.

Renewed Revenue Slowdown in Recent Quarters

2026Q1 revenue fell 9.1% year on year due to shifting demand in the smart device market, and Q2 revenue of KRW 40.4 billion also declined from the prior quarter.

Because the speaker component business is highly dependent on the handset market and reacts directly to its trends, renewed weakness in end demand could increase earnings volatility.

Deteriorating Cash Flow and Balance Sheet

Operating cash flow turned negative at KRW -15.8 billion in 2025 from a positive KRW 7.3 billion in 2024. The debt ratio also climbed steadily from 57.5% in 2022 to 73.1% in 2025, indicating a thinning financial cushion. Prolonged losses could increase the funding burden needed to finance new-business investment.

10

Risk factors

Customer Decision Risk

Mass production and revenue generation from the new e-cigarette product depend entirely on the customer's final launch decision, and any delay or cancellation could push back the timing of new-business revenue contribution, a key precondition for the product segment's earnings-improvement scenario.

Regulatory and Certification Risk

While the auto-injector has completed FDA DMF registration, additional FDA certification steps remain, and any delay in the regulatory approval timeline could make the commercialization schedule uncertain. Medical device certification requirements are strict and may take longer than anticipated.

End-Market Dependency Risk

The component business is heavily dependent on the product cycles of a small number of end markets such as mobile handsets and smartwatches and their major customers. If end-market demand slows or a customer's flagship launch schedule shifts, quarterly earnings volatility could increase.

11

What to watch next

  1. By November 16, 2026

    The statutory filing deadline for the 2026Q3 report, providing the next regular earnings update to check on the component business recovery and product-segment loss trend.

  2. Customer's final launch decision (timing undetermined)

    The customer's launch decision will determine whether mass production of the new e-cigarette product begins, and confirmation could be a catalyst for product-segment revenue expansion.

  3. Ongoing FDA certification progress (monitor periodically)

    Progress on the remaining certification steps for the auto-injector following FDA DMF registration, serving as a gauge for the timing of global commercialization.

  4. Progress toward the Q1 2028 production target

    Development and production-readiness progress on the bendable display order for a global automaker, indicating whether the new automotive electronics growth axis is materializing.

12

Overall view

Despite the 2025 revenue rebound and narrower operating loss, EM-Tech faces the structural challenge of four consecutive years of net losses and 12 consecutive quarters of operating losses.

The core component business remains sensitive to the handset and wearable device cycle and showed renewed signs of revenue slowdown in 2026, while the shift to negative operating cash flow and a rising debt ratio suggest a gradually thinning financial cushion.

On the other hand, the new e-cigarette product has completed development and production readiness and awaits the customer's launch decision, and the auto-injector has completed FDA DMF registration, bringing new-business commercialization into view.

Vendor registration and an order win in automotive electronics could also become an early step toward longer-term customer diversification.

Ultimately, the future earnings trajectory will hinge on whether a seasonal recovery in the component business coincides with successful commercialization of the new ventures, and investors will want to watch the upcoming 2026Q3 report, the customer's launch decision, and the progress of FDA certification together.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. chickstockfi.com
  2. chickstockfi.com
  3. stock.epostphone.kr
  4. investing.com
  5. butler.works
  6. chickstockfi.com
  7. leading.co.kr
  8. file.alphasquare.co.kr
  9. chickstockfi.com
  10. alpha-lenz.com
  11. thevc.kr
  12. comp.wisereport.co.kr
  13. comp.fnguide.com
  14. dailyinvest.kr
  15. catch.co.kr
  16. comp.wisereport.co.kr
  17. saramin.co.kr
  18. dart.fss.or.kr

Report written 2026-10-01 · Data as of 2026-09-30

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.